You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AKTS Exercise Disclosure
Czibere Akos · SEC Form 4 · Filed Sep 24, 2026
Exercise
Calculated transaction value
$0
Czibere Akos Chief Medical Officer
AKTS
Aktis Oncology, Inc.
AKTS
Transaction date
Sep 23, 2026
Public filing date
Sep 24, 2026
Filing lag
Filed 1 day later
AKTS daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 12,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-401014
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$320.5K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aktis Oncology, Inc. AKTS | Exercise | Sep 23, 2026 | $61.88K |
| Aktis Oncology, Inc. AKTS | Sale | Sep 23, 2026 | $155.65K |
| Aktis Oncology, Inc. AKTS Current | Exercise | Sep 23, 2026 | $0 |
| Aktis Oncology, Inc. AKTS | Sale | Sep 23, 2026 | $102.97K |